“Attention Investors: Don’t Miss Out on Your Chance to Take Action Against Kyverna Therapeutics Inc – Important Deadline Approaching!”

New Securities Class Action Filed Against Kyverna Therapeutics, Inc. Deadline Approaching for Lead Plaintiff New York, Jan. 24, 2025 (GLOBE NEWSWIRE) The law firm of Kirby McInerney LLP has notified investors about the upcoming deadline to seek the role of lead plaintiff in a federal securities class action against Kyverna Therapeutics, Inc. (NASDAQ: KYTX). The…

Read More

“Breaking News: Marqeta Inc. Faces Fraud Lawsuit – What This Means for the Business and Professional Services Industry”

Latest Securities Lawsuit Filed Against Marqeta, Inc. Bleichmar Fonti & Auld LLP Takes Legal Action On January 24, 2025, leading securities law firm Bleichmar Fonti & Auld LLP announced that a lawsuit has been filed against Marqeta, Inc. (NASDAQ:MQ) and certain of the Company’s senior executives for potential violations of the federal securities laws. If…

Read More

“BioAge Labs Faces Class Action Lawsuit After Stock Decline: What You Need to Know”

Investor Alert: Lawsuit Filed Against BioAge Labs, Inc. January 24, 2025 Leading securities law firm Bleichmar Fonti & Auld LLP has announced that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ:BIOA) and certain senior executives for potential violations of federal securities laws. Investors who have invested in BioAge are encouraged to obtain additional…

Read More

“Breaking News: Applied Therapeutics Faces Lawsuit for FR Violations – A Quirky and Informative Take!”

Exciting News from Bleichmar Fonti & Auld LLP! A Lawsuit filed against Applied Therapeutics, Inc. NEW YORK, NY / ACCESS Newswire / January 24, 2025 Attention all investors! Leading securities law firm Bleichmar Fonti & Auld LLP has announced that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ:APLT) and certain senior executives of…

Read More